UBE2N and breast carcinoma: It was demonstrated that Ubc13 is upregulated in tumor tissue samples of the breast, prostate, colon, pancreas and in lymphoma [155, 293] and that upregulated Ubc13 in breast cancer is correlated with reduced survival.